Publikasi Scopus 2024 per tanggal 31 Mei 2024 (409 artikel)

Leong E.; Cifuentes-González C.; Hu Y. W J.; Perumal Samy R.; Khairallah M.; Rojas-Carabali W.; Putera I.; de-la-Torre A.; Agrawal R.
Leong, Evangeline (59133114400); Cifuentes-González, Carlos (57222074348); Hu Y. W, Jeremy (57214136942); Perumal Samy, Ramar (56153274200); Khairallah, Moncef (7004503022); Rojas-Carabali, William (57219659910); Putera, Ikhwanuliman (56485949000); de-la-Torre, Alejandra (15822066700); Agrawal, Rupesh (7201475180)
59133114400; 57222074348; 57214136942; 56153274200; 7004503022; 57219659910; 56485949000; 15822066700; 7201475180
Clinical Insights: Antimicrobial Therapy for Infectious Uveitis
2024
Ocular Immunology and Inflammation
0
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Neuroscience Research Group (NEUROS), Neurovitae Center for Neuroscience, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia; Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore; Ocular Infections and Antimicrobial Group, Singapore Eye Research Institute, Singapore, Singapore; Department of Ophthalmology, Faculty of Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia – Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia; Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Lee Kong Chian School of Medicine, Singapore, Singapore; Duke NUS Medical School, Singapore, Singapore
Leong E., Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Cifuentes-González C., Neuroscience Research Group (NEUROS), Neurovitae Center for Neuroscience, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia, Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore; Hu Y. W J., Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore; Perumal Samy R., Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, Ocular Infections and Antimicrobial Group, Singapore Eye Research Institute, Singapore, Singapore; Khairallah M., Department of Ophthalmology, Faculty of Medicine, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia; Rojas-Carabali W., Neuroscience Research Group (NEUROS), Neurovitae Center for Neuroscience, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia, Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; Putera I., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia – Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; de-la-Torre A., Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore; Agrawal R., Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore, Ocular Infections and Antimicrobial Group, Singapore Eye Research Institute, Singapore, Singapore, Lee Kong Chian School of Medicine, Singapore, Singapore, Duke NUS Medical School, Singapore, Singapore
Infectious uveitis is a major global cause of vision impairment. Despite the eye’s immune privilege, afforded by the blood-ocular barrier that restricts microbial entry, several pathogens such as bacteria, viruses, fungi, and parasites can still infiltrate and cause ocular infections and complications. Clinicians often encounter significant challenges in treating infectious uveitis due to limited or ineffective treatment options. Modern molecular techniques and imaging can aid in diagnosing and assessing intraocular infections. Various antimicrobial therapies exist, spanning topical and systemic treatments, but these are constrained by issues like drug concentration, penetration, effective duration, toxicity, and side effects. Treatment approaches also differ based on the infection’s etiology. This review provides recent updates on antimicrobial therapies from a clinical perspective, covering topical, systemic, and regional treatments for infectious uveitis. © 2024 Taylor & Francis Group, LLC.
antimicrobial; infectous uveitis; intraocular infection; therapies; Uveitis
National Medical Research Council, NMRC; Tan Tock Seng Hospital; National Healthcare Group Eye Institute; Ministry of Education - Singapore, MOE
Authors gratefully acknowledge the funding agency \u201CNational Medical Research Council of Singapore (NMRC), or MOE, and other clinicians awarded a research grant to Prof. Rupesh Agrawal, Senior Consultant, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.
Taylor and Francis Ltd.
09273948
Review
Q1
805
5924